A double-blind study with volunteers was performed to determine the incidence and severity of thrombophlebitis associated with cephalothin, cephapirin, cefamandole, and a water control. Although there were no statistical differences in the incidence of thrombophlebitis, cephalothin resulted in significantly more severe thrombophlebitis compared with the other agents.
The intravenous administration of cephalothin is associated with a high incidence of thrombophlebitis (7, 8) . Cephapirin is a newer cephalosporin similar in bacterial spectrum to cephalothin (1) . In single-blind studies, investigators found that cephapirin caused less thrombophlebitis than that reported for cephalothin (2, 5) . In two reported double-blind studies, Inagaki and Bodey found a significant reduction in thrombophlebitis with cephapirin; however, this could not be substantiated by Carrizosa et al. (3, 4) . The inability to perform a truly controlled study in patients because of the need for other intravenous medications perhaps contributed to these conflicting data. Cefamandole is a new cephalosporin with a somewhat broader gram-negative spectrum than that of cephalothin (6) . There are no studies comparing the incidence of thrombophlebitis with cefamandole to other cephalosporin antibiotics. We undertook a double-blind study in normal volunteers to determine the incidence and severity of thrombophlebitis associated with the administration of cephalothin, cephapirin, cefamandole, and a vehicle control.
MATERIALS AND METHODS
Prior to performance, the study was reviewed and approved by four experimentation committees. After a detailed explanation, informed consent was obtained from 16 cephalothin, 2 g every 6 h; (ii) cephapirin, 2 g every 6 h; (iii) cefamandole, 2 g every 6 h; and (iv) sterile water control, 20 ml every 6 h. The medications were given intravenously via Soluset in a total volume of 100 ml over a 30-min period. A 2-day rest period separated each 5-day infusion period.
The infusion site was examined and scored twice daily by two independent observers without knowledge of the medication received or the other observers' score. Thrombophlebitis was graded from 0 to +4 according to the following scale: 0, no evidence of thrombophlebitis; +1, erythema and tenderness along the vein less than 2.5 cm above the infusion site; +2, erythema and mild tenderness along the vein more than 2.5 cm above the infusion site; +3, erythema and moderate discomfort along the vein more than 2.5 cm above the infusion site; and +4, erythema and severe discomfort along the vein more than 2.5 cm abQve the infusion site. When a +4 score was rendered, the intravenous infusion was stopped, and hot soaks and elevation were applied to the affected arm. In all cases, the discomfort and inflammation abated within 24 h. If infiltration of fluids into subcutaneous tissue occurred, the infusion site was changed to the opposite ann.
RESULTS
Each volunteer received a morning and evening thrombophlebitis score for a total of 5 days. If +4 thrombophlebitis was graded, a +4 score was given for all subsequent grades. Only 3 of 16 volunteers receiving cephapirin and water, 1 of 16 receiving cephalothin, and 0 of 16 receiving cefamandole had no thrombophlebitis. Table 1 shows the mean thrombophlebits score for the three cephalosporins and water for each day of the study. The results were analyzed by the Friedman descriptive two-way analysis of variance by ranks. There were no statistical differences in the first 3 days of therapy, but by day 4 cephalothin reached a significantly higher mean of thrombophlebitis (P < 0.01), ANTIMICROB. AGENTS CHEMOTHER. which was maintained throughout the duration of the study. Infiltration of intravenous fluid was not a significant problem. Of the infusions that needed to be restarted, equal numbers appeared in the cephalothin, cephapirin, cefamandole, and water groups. DISCUSSION Although there were no significant differences in the incidence of thrombophlebitis resulting from infusion ofwater, cephapirin, cefamandole, and cephalothin, there was a statistically significant difference in the severity of thrombophlebitis. Cephalothin produced more severe thrombophlebitis than cephapirin, cefamandole, or water. There were no statistical differences in the severity of thrombophlebitis caused by cephapirin, cefamandole, and water.
Disadvantages of previously reported thrombophlebitis studies have been lack of control to assess incidence and severity of thrombophlebitis from the infusion vehicle alone (3) (4) (5) and inability to use each patient as his own control (4) . The administration of water and each cephalosporin to all volunteers in the study circumvented these difficulties. The almost uniform need for other intravenous medications, the presence of other diseases, and the inability to assess the contribution of the vehicle alone restrict a controlled study to a volunteer population.
Our results are in agreement with those of Lane et al. (5) There do not appear to be any major differences in the severity of thrombophlebitis caused by water, cephapirin, and cefamandole.
Our current study demonstrates that cephapirin and cefamandole produce less severe inflammation than cephalothin when evaluated in a 5-day infusion period. If pharmacological and microbiological parameters prove to be equal, it would appear that cephapirin and cef-amandole are more desirable intravenous cephalosporins than cephalothin.
